EZH2 inactivation drives MAPK-dependent vulnerability to MEK inhibition in RAS-mutant CMML
Eva Gruden(Medical University of Graz), Armin Zebisch(Medical University of Graz), Sayantanee Dutta(Medical University of Graz), Karl Kashofer(Medical University of Graz), Gudrun Pregartner(Medical University of Graz), Heinz Sill(Medical University of Graz), Annkristin Heine(Medical University of Graz), Albert Woelfler(University of Graz), Gerald Höefler(Medical University of Graz), Melanie Kienzl(Medical University of Graz), K. Lind(Medical University of Graz), Marie-Christina Mayer(Medical University of Graz), Panagiota Chaida(Medical University of Graz), Katarina Vizar-Cisarova(Medical University of Graz), Klaus Geissler(Sigmund Freud Privatuniversität Wien), Akshaya Kailasnathan(Medical University of Graz), Jennifer Neiss(Medical University of Graz), Andreas Reinisch(Medical University of Graz), Gerhard Bachmaier(Medical University of Graz), Sonja Wurm(Medical University of Graz), Johannes Fosselteder(Medical University of Graz), Bianca Perfler(Medical University of Graz)
Cited by 0
Related Papers
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
|Cancer and Metastasis Reviews|2020|334
A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode
|Bipolar Disorders|2018|246